Lobe Sciences Ltd.
LOBE
CNSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -101.97% | -42.50% | 15.58% | 71.84% | -559.90% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,100.99% | -125.72% | -47.32% | -87.95% | 2,052.53% |
| Change in Net Operating Assets | 86.37% | 276.80% | -35.72% | -9.83% | 33.27% |
| Cash from Operations | -0.10% | -13.13% | -45.22% | -1,599.04% | 95.60% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -200.14% | 4,519.87% | -- | -- | -33.19% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.04% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3,415.32% | -200.00% | -- | -- | -- |
| Cash from Financing | -99.93% | 1,875.64% | -- | -- | -33.52% |
| Foreign Exchange rate Adjustments | -230.05% | 143.86% | -296.43% | 1,073.91% | -136.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.28% | 627,877.78% | 99.42% | -201.45% | 745.00% |